Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study Meeting Abstract
| Authors: | Janjigian, Y. Y.; Kawazoe, A.; Yanez, P. E.; Luo, S.; Lonardi, S.; Kolesnik, O.; Barajas, O.; Bai, Y.; Shen, L.; Tang, Y.; Wyrwicz, L.; Shitara, K.; Qin, S.; Van Cutsem, E.; Tabernero, J.; Li, L.; Shih, C. S.; Bhagia, P.; Chung, H. C. C.; on behalf of the KEYNOTE-811 investigators |
| Abstract Title: | Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120602115 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.4013 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4013 -- Source: Wos |
